The University of Chicago Header Logo

Connection

Eugene Chang to Fatty Liver

Back to Details
This is a "connection" page, showing publications Eugene Chang has written about Fatty Liver.
Eugene Chang
Connection Strength
1.091
Fatty Liver
  1. CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes. PLoS One. 2018; 13(10):e0206152.
    View in: PubMed
    Score: 0.540
  2. Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats. World J Gastroenterol. 2015 Jul 07; 21(25):7754-63.
    View in: PubMed
    Score: 0.430
  3. Sirt1 and Sirt6 mediate beneficial effects of rosiglitazone on hepatic lipid accumulation. PLoS One. 2014; 9(8):e105456.
    View in: PubMed
    Score: 0.101
  4. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance. Diabetes. 2011 Apr; 60(4):1168-76.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.